Ren ZH, Hu CY, He HR, Li YJ, Lyu J. Global and regional burdens of oral cancer from 1990 to 2017: results from the global burden of disease study. Cancer Commun. 2020;40:81–92.
Google ScholarÂ
Bhol CS, Mishra SR, Patil S, Sahu SK, Kirtana R, Manna S, et al. PAX9 reactivation by inhibiting DNA methyltransferase triggers antitumor effect in oral squamous cell carcinoma. Biochim Biophys Acta Mol Basis Dis. 2022;1868:166428.
Google ScholarÂ
Mahapatra KK, Mishra SR, Dhiman R, Bhutia SK. Stonin 2 activates lysosomal-mTOR axis for cell survival in oral cancer. Toxicol In Vitro. 2023;88:105561.
Google ScholarÂ
Bhol CS, Senapati PK, Kar RK, Chew G, Mahapatra KK, Lee E, et al. Autophagy paradox: Genetic and epigenetic control of autophagy in cancer progression. Cancer Lett. 2025;630:217909.
Google ScholarÂ
Bhol CS, Panigrahi DP, Praharaj PP, Mahapatra KK, Patra S, Mishra SR, et al. Epigenetic modifications of autophagy in cancer and cancer therapeutics. Semin Cancer Biol. 2020;66:22–33.
Hu X, Sui X, Li L, Huang X, Rong R, Su X, et al. Protocadherin 17 acts as a tumour suppressor inducing tumour cell apoptosis and autophagy, and is frequently methylated in gastric and colorectal cancers. J Pathol. 2013;229:62–73.
Google ScholarÂ
You Y, Yang W, Qin X, Wang F, Li H, Lin C, et al. ECRG4 acts as a tumor suppressor and as a determinant of chemotherapy resistance in human nasopharyngeal carcinoma. Cell Oncol. 2015;38:205–14.
Google ScholarÂ
Liu X, Hu X, Kuang Y, Yan P, Li L, Li C, et al. BCLB, methylated in hepatocellular carcinoma, is a starvation stress sensor that induces apoptosis and autophagy through the AMPK-mTOR signaling cascade. Cancer Lett. 2017;395:63–71.
Google ScholarÂ
Bhol CS, Patil S, Sahu BB, Patra SK, Bhutia SK. The clinical significance and correlative signaling pathways of paired box gene 9 in development and carcinogenesis. Biochim Biophys Acta Rev Cancer. 2021;1876:188561.
Google ScholarÂ
Bonczek O, Balcar VJ, Šerý OJCG. PAX9 gene mutations and tooth agenesis: a review. Clin Genet. 2017;92:467–76.
Google ScholarÂ
Shi M, Ren S, Chen H, Li J, Huang C, Li Y, et al. Alcohol drinking inhibits NOTCH–PAX9 signaling in esophageal squamous epithelial cells. J Pathol. 2021;253:384–95.
Google ScholarÂ
Xiong Z, Ren S, Chen H, Liu Y, Huang C, Zhang YL, et al. PAX9 regulates squamous cell differentiation and carcinogenesis in the oro-oesophageal epithelium. J Pathol. 2018;244:164–75.
Google ScholarÂ
Gerber JK, Richter T, Kremmer E, Adamski J, Höfler H, Balling R, et al. Progressive loss of PAX9 expression correlates with increasing malignancy of dysplastic and cancerous epithelium of the human oesophagus. J Pathol. 2002;197:293–7.
Google ScholarÂ
Tan B, Wang J, Song Q, Wang N, Jia Y, Wang C, et al. Prognostic value of PAX9 in patients with esophageal squamous cell carcinoma and its prediction value to radiation sensitivity. Mol Med Rep. 2017;16:806–16.
Google ScholarÂ
Hata S, Hamada J, Maeda K, Murai T, Tada M, Furukawa H, et al. PAX4 has the potential to function as a tumor suppressor in human melanoma. Int J Oncol. 2008;33:1065–71.
Google ScholarÂ
Rahman MM, Lai YC, Husna AA, Chen HW, Tanaka Y, Kawaguchi H, et al. Micro RNA transcriptome profile in canine oral melanoma. Int J Mol Sci. 2019;20:4832.
Google ScholarÂ
Das CK, Parekh A, Parida PK, Bhutia SK, Mandal M. Lactate dehydrogenase A regulates autophagy and tamoxifen resistance in breast cancer. Biochim Biophys Acta Mol Cell Res. 2019;1866:1004–18.
Google ScholarÂ
Mukhopadhyay S, Das DN, Panda PK, Sinha N, Naik PP, Bissoyi A, et al. Autophagy protein ULK1 promotes mitochondrial apoptosis through reactive oxygen species. Free Radic Biol Med. 2015;89:311–21.
Google ScholarÂ
Naik PP, Mukhopadhyay S, Praharaj PP, Bhol CS, Panigrahi DP, Mahapatra KK, et al. Secretory clusterin promotes oral cancer cell survival via inhibiting apoptosis by activation of autophagy in AMPK/mTOR/ULK1 dependent pathway. Life Sci. 2021;264:118722.
Google ScholarÂ
Pramanik KK, Mishra RJECR. ERK-mediated upregulation of matrix metalloproteinase-2 promotes the invasiveness in human oral squamous cell carcinoma (OSCC). Exp Cell Res. 2022;411:112984.
Google ScholarÂ
Panda PK, Naik PP, Praharaj PP, Meher BR, Gupta PK, Verma RS, et al. Abrus agglutinin stimulates BMP-2-dependent differentiation through autophagic degradation of β-catenin in colon cancer stem cells. Mol Carcinog. 2018;57:664–77.
Google ScholarÂ
Sinha N, Panda PK, Naik PP, Maiti TK, Bhutia SK. Abrus agglutinin targets cancer stem-like cells by eliminating self-renewal capacity accompanied with apoptosis in oral squamous cell carcinoma. Tumour Biol. 2017;39:1010428317701634.
Google ScholarÂ
Patra S, Bhol CS, Panigrahi DP, Praharaj PP, Pradhan B, Jena M, et al. Gamma irradiation promotes chemo-sensitization potential of gallic acid through attenuation of autophagic flux to trigger apoptosis in an NRF2 inactivation signalling pathway. Free Radic Biol Med. 2020;160:111–24.
Google ScholarÂ
Panigrahi DP, Bhol CS, R N, Nagini S, Patil S, Maiti TK, et al. Abrus agglutinin inhibits oral carcinogenesis through inactivation of NRF2 signaling pathway. Int J Biol Macromol. 2020;155:1123–32.
Google ScholarÂ
Wong SW, Han D, Zhang H, Liu Y, Zhang X, Miao MZ, et al. Nine novel PAX9 mutations and a distinct tooth agenesis genotype-phenotype. J Dent Res. 2018;97:155–62.
Google ScholarÂ
Liang J, Song G, Li Q, Bian Z. Novel missense mutations in PAX9 causing oligodontia. Arch Oral Biol. 2012;57:784–9.
Google ScholarÂ
Lei Y, Klionsky DJ. Transcriptional regulation of autophagy and its implications in human disease. Cell Death Differ. 2023;30:1416–29.
Google ScholarÂ
Di Malta C, Cinque L, Settembre C. Transcriptional regulation of autophagy: mechanisms and diseases. Front Cell Dev Biol. 2019;7:114.
Google ScholarÂ
Settembre C, Di Malta C, Polito VA, Garcia Arencibia M, Vetrini F, Erdin S, et al. TFEB links autophagy to lysosomal biogenesis. Science. 2011;332:1429–33.
Google ScholarÂ
Roczniak-Ferguson A, Petit CS, Froehlich F, Qian S, Ky J, Angarola B, et al. The transcription factor TFEB links mTORC1 signaling to transcriptional control of lysosome homeostasis. Sci Signal. 2012;5:ra42.
Google ScholarÂ
Wang T, Qin Y, Ye Z, Jing DS, Fan GX, Liu MQ, et al. A new glance at autophagolysosomal-dependent or -independent function of transcriptional factor EB in human cancer. Acta Pharmacol Sin. 2023;44:1536–48.
Google ScholarÂ
Tan A, Prasad R, Lee C, Jho EH. Past, present, and future perspectives of transcription factor EB (TFEB): mechanisms of regulation and association with disease. Cell Death Differ. 2022;29:1433–49.
Google ScholarÂ
Webb AE, Brunet A. FOXO transcription factors: key regulators of cellular quality control. Trends Biochem Sci. 2014;39:159–69.
Google ScholarÂ
Xie R, Wang F, McKeehan WL, Liu L. Autophagy enhanced by microtubule- and mitochondrion-associated MAP1S suppresses genome instability and hepatocarcinogenesis. Cancer Res. 2011;71:7537–46.
Google ScholarÂ
Agarwal S, Bell CM, Taylor SM, Moran RG. p53 deletion or hotspot mutations enhance mTORC1 activity by altering lysosomal dynamics of TSC2 and Rheb. Mol Cancer Res. 2016;14:66–77.
Google ScholarÂ
Segala G, David M, de Medina P, Poirot MC, Serhan N, Vergez F, et al. Dendrogenin A drives LXR to trigger lethal autophagy in cancers. Nat Commun. 2017;8:1903.
Google ScholarÂ
Silvente-Poirot S, Segala G, Poirot MC, Poirot M. Ligand-dependent transcriptional induction of lethal autophagy: a new perspective for cancer treatment. Autophagy. 2018;14:555–7.
Google ScholarÂ
Hu L, Wang Y, Chen Z, Fu L, Wang S, Zhang X, et al. Hsp90 inhibitor SNX-2112 enhances TRAIL-induced apoptosis of human cervical cancer cells via the ROS-mediated JNK-p53-autophagy-DR5 pathway. Oxid Med Cell Longev. 2019;2019:9675450.
Google ScholarÂ
Petherick KJ, Williams AC, Lane JD, Ordóñez-Morán P, Huelsken J, Collard TJ, et al. Autolysosomal β-catenin degradation regulates Wnt-autophagy-p62 crosstalk. EMBO J. 2013;32:1903–16.
Google ScholarÂ
Qu X, Liu H, Song X, Sun N, Zhong H, Qiu X, et al. Effective degradation of EGFR(L858R+T790M) mutant proteins by CRBN-based PROTACs through both proteosome and autophagy/lysosome degradation systems. Eur J Med Chem. 2021;218:113328.
Google ScholarÂ
Tan X, Sun Y, Thapa N, Liao Y, Hedman AC, Anderson RA. LAPTM4B is a PtdIns(4,5)P2 effector that regulates EGFR signaling, lysosomal sorting, and degradation. EMBO J. 2015;34:475–90.
Google ScholarÂ
Zhu Z, Li J, Shen S, Al-Furas H, Li S, Tong Y, et al. Targeting EGFR degradation by autophagosome degraders. Eur J Med Chem. 2024;270:116345.
Google ScholarÂ
Jones S, Cunningham DL, Rappoport JZ, Heath JK. The non-receptor tyrosine kinase Ack1 regulates the fate of activated EGFR by inducing trafficking to the p62/NBR1 pre-autophagosome. J Cell Sci. 2014;127:994–1006.
Google ScholarÂ
Byun S, Lee SY, Lee J, Jeong CH, Farrand L, Lim S, et al. USP8 is a novel target for overcoming gefitinib resistance in lung cancer. Clin Cancer Res. 2013;19:3894–904.
Google ScholarÂ
Ribeiro FA, Noguti J, Oshima CT, Ribeiro DA. Effective targeting of the epidermal growth factor receptor (EGFR) for treating oral cancer: a promising approach. Anticancer Res. 2014;34:1547–52.
Google ScholarÂ
Chung CH, Ely K, McGavran L, Varella-Garcia M, Parker J, Parker N, et al. Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas. J Clin Oncol. 2006;24:4170–6.
Google ScholarÂ
Huang YK, Peng BY, Wu CY, Su CT, Wang HC, Lai HC. DNA methylation of PAX1 as a biomarker for oral squamous cell carcinoma. Clin Oral Investig. 2014;18:801–8.
Google ScholarÂ
Cheng SJ, Chang CF, Lee JJ, Chen HM, Wang HJ, Liou YL, et al. Hypermethylated ZNF582 and PAX1 are effective biomarkers for detection of oral dysplasia and oral cancer. Oral Oncol. 2016;62:34–43.
Google ScholarÂ
Zeng L, Yun W, Luo WL. A comprehensive analysis of the role of PAX9 in Head and neck squamous cell carcinoma. Curr Mol Med. 2025;25:1413–26.
Google ScholarÂ
Liu J, Wang YQ, Niu HB, Zhang CX. PAX9 functions as a tumor suppressor gene for cervical cancer via modulating cell proliferation and apoptosis. Kaohsiung J Med Sci. 2022;38:357–66.
Google ScholarÂ
Bhol CS, Sethi G, Bhutia SK. Abstract P50: PAX9 activates cell death via autophagic degradation of EGFR in oral squamous cell carcinoma. Cancer Res. 2024;84:P50.
Google ScholarÂ
Tang H, Long Q, Zhuang K, Han K, Zhang X, Guo H, et al. Retinoblastoma tumor suppressor gene 1 enhances 5-Fluorouracil chemosensitivity through SDF-1/CXCR4 axis by regulating autophagy in gastric cancer. Pathol Res Pract. 2021;224:153532.
Google ScholarÂ
Soto JA, RodrÃguez-AntolÃn C, Vera O, PernÃa O, Esteban-RodrÃguez I, Dolores Diestro M, et al. Transcriptional epigenetic regulation of Fkbp1/Pax9 genes is associated with impaired sensitivity to platinum treatment in ovarian cancer. Clin Epigenetics. 2021;13:167.
Google ScholarÂ

